Marsh & McLennan Companies (NYSE:MRSH) Price Target Raised to $203.00

Marsh & McLennan Companies (NYSE:MRSH) had its target price boosted by Keefe, Bruyette & Woods from $200.00 to $203.00 in a research note published on Friday,Benzinga reports. Keefe, Bruyette & Woods currently has a market perform rating on the financial services provider’s stock.

A number of other analysts have also recently commented on MRSH. Barclays dropped their price objective on Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a research report on Wednesday, April 8th. Evercore lowered their price target on Marsh & McLennan Companies from $237.00 to $236.00 and set an “outperform” rating for the company in a report on Wednesday, January 7th. Cantor Fitzgerald lifted their price target on Marsh & McLennan Companies from $208.00 to $212.00 and gave the company an “overweight” rating in a report on Monday, February 2nd. Raymond James Financial upgraded Marsh & McLennan Companies from an “outperform” rating to a “strong-buy” rating and set a $225.00 price target for the company in a report on Tuesday, February 17th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating for the company in a research report on Thursday, April 9th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Marsh & McLennan Companies presently has a consensus rating of “Hold” and an average price target of $205.33.

Marsh & McLennan Companies Trading Down 3.4%

Marsh & McLennan Companies stock opened at $176.35 on Friday. The stock has a market cap of $85.38 billion, a PE ratio of 22.04, a PEG ratio of 2.51 and a beta of 0.75. The stock’s 50-day moving average is $173.66. Marsh & McLennan Companies has a 52 week low of $164.89 and a 52 week high of $235.78. The company has a current ratio of 1.11, a quick ratio of 1.10 and a debt-to-equity ratio of 1.28.

Marsh & McLennan Companies (NYSE:MRSH) last posted its quarterly earnings data on Thursday, April 16th. The financial services provider reported $3.29 EPS for the quarter, topping analysts’ consensus estimates of $3.21 by $0.08. The firm had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a return on equity of 31.87% and a net margin of 14.26%.The company’s revenue was up 7.6% on a year-over-year basis. On average, equities analysts predict that Marsh & McLennan Companies will post 9.61 EPS for the current year.

Marsh & McLennan Companies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Thursday, April 9th will be given a dividend of $0.90 per share. The ex-dividend date of this dividend is Thursday, April 9th. This represents a $3.60 annualized dividend and a yield of 2.0%. Marsh & McLennan Companies’s dividend payout ratio is 45.00%.

Insider Activity

In other news, CEO John Q. Doyle sold 16,655 shares of the business’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total transaction of $3,052,861.50. Following the completion of the sale, the chief executive officer owned 116,811 shares in the company, valued at approximately $21,411,456.30. The trade was a 12.48% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.38% of the company’s stock.

Institutional Trading of Marsh & McLennan Companies

Institutional investors have recently modified their holdings of the company. Pinnacle Bancorp Inc. purchased a new stake in shares of Marsh & McLennan Companies during the 3rd quarter worth about $25,000. Solstein Capital LLC purchased a new stake in shares of Marsh & McLennan Companies during the 4th quarter worth about $25,000. SHP Wealth Management purchased a new stake in shares of Marsh & McLennan Companies during the 4th quarter worth about $26,000. KERR FINANCIAL PLANNING Corp purchased a new stake in shares of Marsh & McLennan Companies during the 4th quarter worth about $27,000. Finally, Golden State Wealth Management LLC purchased a new stake in shares of Marsh & McLennan Companies during the 4th quarter worth about $27,000. Hedge funds and other institutional investors own 87.99% of the company’s stock.

Key Marsh & McLennan Companies News

Here are the key news stories impacting Marsh & McLennan Companies this week:

• Positive Sentiment: Q1 results beat expectations — non‑GAAP EPS $3.29 vs. ~$3.21 estimate and revenue roughly $7.3B with ~8% year‑over‑year growth; Mercer/consulting drove strength. Marsh (MRSH) Beats Q1 Earnings and Revenue Estimates
• Positive Sentiment: Earnings call highlighted continued growth initiatives and AI investments that management says support long‑term revenue/consulting momentum — a potential positive catalyst for future margins. Marsh & McLennan Earnings Call Highlights Growth and AI
• Positive Sentiment: Keefe, Bruyette & Woods raised its price target to $203 (market‑perform), implying upside from current levels — a modest vote of confidence from an analyst. Price Target Raise
• Neutral Sentiment: Commentary and analyst pieces note that valuation looks more attractive after the pullback — could attract value buyers but depends on execution and margin trends. Marsh & McLennan: The Valuation May Finally Be Here
• Negative Sentiment: Bank of America maintained a sell rating on MRSH, providing a counterweight to upbeat results and likely contributing to short‑term selling pressure. Bank of America Sticks to Sell Rating
• Negative Sentiment: Company disclosed a new regulation‑category risk that could materially affect financial performance — an added uncertainty that can weigh on sentiment until clarified. Regulatory Risk Disclosure

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.